REGLAN LITIGATION DESIGNATED A MASS TORT IN PHILADELPHIA COUNTY

The Honorable Judge Sandra Moss of the Philadelphia Court of Common Pleas has designated the Reglan® litigation a "mass tort." I recently had the pleasure of interviewing Judge Moss concerning the mass tort system. My article was published in The Verdict, a publication of the Philadelphia Trial Lawyers Association. http://sheller.com/uploads/Homolash_PTLA_article_on_Judge_Moss.pdf
I serve on the association's Future Leaders' Committee, a small group of attorneys thought to be the future leaders of the organization.

The anti-nausea medication Reglan®, or metoclopramide, is prescribed to treat gastrointestinal disorders such as acid reflux, diabetic gastroperesis and nausea. Reglan® increases stomach and small intestine contractions and can be prescribed to children, adults and pregnant women.

The Food and Drug Administration has only approved Reglan® for short term use, however, a third of its users are on the drug for a year or longer and are classified as long-term users. A number of serious side effects have been associated with continuous use of Reglan® including dangerous neurological conditions.

Patients taking Reglan® can develop the condition known as tardive dyskinesia. Tardive dyskinesia is a neurological condition that causes the patient to suffer from jerky and involuntary movement in the face, lips, tongue, mouth, and sometimes other parts of the body. Tardive dyskinesia is often incurable and can permanently debilitate the patient.

I have experience representing individuals suffering from tardive dyskinesia in other drug injury litigations which will benefit you greatly in the Reglan litigation.

If you or someone you know have taken Reglan® and are now suffering from severe neurological conditions such as tardive dyskinesia please contact me at chomolash@sheller.com or 215-790-7379 today.